首页> 外文期刊>Toxicology: An International Journal Concerned with the Effects of Chemicals on Living Systems >Allylamine and beta-aminopropionitrile induced aortic medial necrosis: mechanisms of synergism.
【24h】

Allylamine and beta-aminopropionitrile induced aortic medial necrosis: mechanisms of synergism.

机译:烯丙胺和β-氨基丙腈诱导的主动脉内侧坏死:协同作用的机制。

获取原文
获取原文并翻译 | 示例
           

摘要

We have developed a model of aortic smooth muscle necrosis in adult Sprague Dawley rats by feeding them two vascular toxins (allylamine HCl, or AA, and beta-aminopropionitrile, or betaAPN) in concert for 10 days. Either toxin given alone does not cause aortic lesions. In order to shed light on the mechanism of the synergistic action of these two toxins we fed known modulators of AA or betaAPN toxicity to rats concurrently with the two toxins. As modulators we used (a) semicarbazide (98 mg/kg/day, given 4 h prior to toxins), a known inhibitor of the vascular enzyme SSAO which metabolizes AA; (b) L-cysteine (1.5% in rat chow, beginning 3 days prior to toxins), which has been shown to reduce the toxic effects of betaAPN; and (c) phenelzine sulphate (3 mg/kg/day, given 4 h prior to toxins), an inhibitor of SSAO and potentiator of betaAPN toxicity. Rats were fed various combinations of the toxins and modulators by gavage: water (n = 8); (AA, 100 mg/kg/day) AA + phenelzine (n = 8); AA + semicarbazide (n = 8); AA + L-cysteine (n = 11); (betaAPN, 1 g/kg/day) betaAPN + phenelzine (n = 8); betaAPN + semicarbazide (n = 8); betaAPN + L-cysteine (n = 8); (AA, 100 mg + betaAPN, 1 g/kg/day) AA + betaAPN + phenelzine (n = 9), AA + betaAPN + semicarbazide (n = 8); AA + betaAPN + L-cysteine (n = 12); phenelzine (3 mg/kg/day) (n = 4); semicarbazide (98 mg/kg/day) (n = 4) and L-cysteine (1.5% in rat chow) (n = 4). We found that phenelzine sulphate (a drug previously used in the treatment of hypertension) when given with AA reproduced the AA + betaAPN induced aortic lesions. Phenelzine + betaAPN caused no lesions, but when combined with AA + betaAPN, aortic lesions were intensified and included marked secondary degeneration of the vascular wall. Semicarbazide was found to completely obviate the vascular toxicity of AA + betaAPN. L-Cysteine feeding markedly decreased the incidence and severity of vascular lesions in AA + betaAPN treated rats, but did not change the incidence or severity of heart lesions caused by AA alone. These data indicate that the synergistic necrotizing toxicity of AA + betaAPN is primarily an AA effect. We postulate that some modulating influence of betaAPN (or phenelzine) on tissue distribution, metabolism, or detoxification pathways of AA increases AA's acute vascular toxicity, whereas semicarbazide offers protection by inhibiting the initial deamination of AA to a highly reactive aldehyde.
机译:我们通过为成年大鼠喂食两种血管毒素(盐酸烯丙胺或AA,以及β-氨基丙腈或βAPN)共同开发了成年Sprague Dawley大鼠主动脉平滑肌坏死的模型。单独使用任何一种毒素都不会引起主动脉病变。为了阐明这两种毒素的协同作用机理,我们将两种毒素同时喂给了已知的AA或betaAPN毒性调节剂。作为调节剂,我们使用了:(a)氨基脲(98 mg / kg /天,在毒素作用前4小时给予),一种已知的血管酶SSAO抑制剂,可代谢AA。 (b)L-半胱氨酸(在有毒素的三天前开始,在大鼠食物中的含量为1.5%),已证明可降低βAPN的毒性作用; (c)硫酸苯乙嗪(3 mg / kg /天,在毒素发生前4小时给予),SSAO抑制剂和betaAPN毒性增强剂。通过管饲法给大鼠喂食毒素和调节剂的各种组合:水(n = 8); (AA,100 mg / kg / day)AA +苯乙嗪(n = 8); AA +氨基脲(n = 8); AA + L-半胱氨酸(n = 11); (betaAPN,1 g / kg /天)betaAPN +苯乙嗪(n = 8); betaAPN +氨基脲(n = 8); betaAPN + L-半胱氨酸(n = 8); (AA,100毫克+ betaAPN,1克/千克/天)AA + betaAPN +苯乙嗪(n = 9),AA + betaAPN +氨基脲(n = 8); AA + betaAPN + L-半胱氨酸(n = 12);苯乙嗪(3 mg / kg /天)(n = 4);氨基脲(98 mg / kg /天)(n = 4)和L-半胱氨酸(在大鼠中占1.5%)(n = 4)。我们发现当与AA一起给予时,硫酸苯乙嗪(以前用于治疗高血压的药物)可复制AA + betaAPN诱导的主动脉病变。苯乙嗪+ betaAPN不会引起病变,但是当与AA + betaAPN结合使用时,主动脉病变会加剧,并包括明显的继发性血管壁变性。发现氨基脲可完全消除AA + betaAPN的血管毒性。 L-半胱氨酸喂养显着降低了AA + betaAPN治疗的大鼠中血管病变的发生率和严重程度,但并未改变仅由AA引起的心脏病变的发生率或严重程度。这些数据表明AA + betaAPN的协同坏死毒性主要是AA效应。我们推测,βAPN(或苯乙嗪)对AA的组织分布,代谢或排毒途径的某些调节作用会增加AA的急性血管毒性,而氨基脲则通过抑制AA脱氨成高反应性醛来提供保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号